The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering.
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
The Well News on MSN
FDA to Streamline Approvals for Less Expensive, Generic Biologic Drugs
WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for cheaper, "biosimilar" alternatives to biologic drugs in an effort to reduce ...
It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.
The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological ...
DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...
A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...
According to Nova One Advisor, the U.S. generic drugs market size is expected to be worth around 196.90 billion by 2034, increasing from USD 138.24 billion in 2024, representing a healthy CAGR of 3.6% ...
The U.S. Catholic bishops sharply criticized the Trump administration’s recent approval of the generic abortion drug mifepristone, saying that women and children deserve better care. The Food and Drug ...
Andrew Nixon, a spokesperson for the Health and Human Services Department, stated that the “FDA has very limited discretion” when it comes to deciding to approve a generic drug, NBC News reported. “By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback